vs
Side-by-side financial comparison of AstroNova, Inc. (ALOT) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
AstroNova, Inc. is the larger business by last-quarter revenue ($39.2M vs $28.1M, roughly 1.4× ARS Pharmaceuticals, Inc.). AstroNova, Inc. runs the higher net margin — 1.0% vs -147.1%, a 148.1% gap on every dollar of revenue. On growth, AstroNova, Inc. posted the faster year-over-year revenue change (-3.4% vs -67.6%).
AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
ALOT vs SPRY — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.2M | $28.1M |
| Net Profit | $378.0K | $-41.3M |
| Gross Margin | 36.2% | — |
| Operating Margin | 3.3% | -147.6% |
| Net Margin | 1.0% | -147.1% |
| Revenue YoY | -3.4% | -67.6% |
| Net Profit YoY | 221.5% | -182.8% |
| EPS (diluted) | $0.05 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.2M | $28.1M | ||
| Q3 25 | $36.1M | $32.5M | ||
| Q2 25 | $37.7M | $15.7M | ||
| Q1 25 | — | $8.0M | ||
| Q4 24 | $40.4M | $86.6M | ||
| Q3 24 | $40.5M | $2.1M | ||
| Q2 24 | $33.0M | $500.0K | ||
| Q1 24 | $39.6M | $0 |
| Q4 25 | $378.0K | $-41.3M | ||
| Q3 25 | $-1.2M | $-51.2M | ||
| Q2 25 | $-376.0K | $-44.9M | ||
| Q1 25 | — | $-33.9M | ||
| Q4 24 | $240.0K | $49.9M | ||
| Q3 24 | $-311.0K | $-19.1M | ||
| Q2 24 | $1.2M | $-12.5M | ||
| Q1 24 | $2.7M | $-10.3M |
| Q4 25 | 36.2% | — | ||
| Q3 25 | 32.2% | — | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 35.3% | — | ||
| Q2 24 | 36.3% | — | ||
| Q1 24 | 31.9% | — |
| Q4 25 | 3.3% | -147.6% | ||
| Q3 25 | -2.0% | -163.7% | ||
| Q2 25 | 1.5% | -302.9% | ||
| Q1 25 | — | -466.3% | ||
| Q4 24 | 3.1% | 54.5% | ||
| Q3 24 | 2.6% | -1051.6% | ||
| Q2 24 | 4.1% | -3068.0% | ||
| Q1 24 | 9.9% | — |
| Q4 25 | 1.0% | -147.1% | ||
| Q3 25 | -3.4% | -157.4% | ||
| Q2 25 | -1.0% | -285.6% | ||
| Q1 25 | — | -425.7% | ||
| Q4 24 | 0.6% | 57.7% | ||
| Q3 24 | -0.8% | -925.0% | ||
| Q2 24 | 3.6% | -2503.2% | ||
| Q1 24 | 6.8% | — |
| Q4 25 | $0.05 | $-0.41 | ||
| Q3 25 | $-0.16 | $-0.52 | ||
| Q2 25 | $-0.05 | $-0.46 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | $0.03 | $0.52 | ||
| Q3 24 | $-0.04 | $-0.20 | ||
| Q2 24 | $0.15 | $-0.13 | ||
| Q1 24 | $0.37 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $76.9M | $114.3M |
| Total Assets | $140.8M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $245.0M | ||
| Q3 25 | $3.9M | $288.2M | ||
| Q2 25 | $5.4M | $240.1M | ||
| Q1 25 | — | $275.7M | ||
| Q4 24 | $4.4M | $314.0M | ||
| Q3 24 | $4.8M | $204.6M | ||
| Q2 24 | $4.0M | $218.7M | ||
| Q1 24 | $4.5M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $76.9M | $114.3M | ||
| Q3 25 | $75.8M | $147.7M | ||
| Q2 25 | $76.6M | $192.3M | ||
| Q1 25 | — | $229.0M | ||
| Q4 24 | $92.2M | $256.8M | ||
| Q3 24 | $91.8M | $201.0M | ||
| Q2 24 | $91.2M | $215.2M | ||
| Q1 24 | $90.3M | $223.9M |
| Q4 25 | $140.8M | $327.7M | ||
| Q3 25 | $143.1M | $372.8M | ||
| Q2 25 | $150.3M | $313.5M | ||
| Q1 25 | — | $327.3M | ||
| Q4 24 | $166.5M | $351.2M | ||
| Q3 24 | $169.0M | $217.6M | ||
| Q2 24 | $126.6M | $222.0M | ||
| Q1 24 | $133.3M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $-43.5M |
| Free Cash FlowOCF − Capex | $3.3M | — |
| FCF MarginFCF / Revenue | 8.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 9.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $-43.5M | ||
| Q3 25 | $249.0K | $-47.0M | ||
| Q2 25 | $4.4M | $-39.6M | ||
| Q1 25 | — | $-40.7M | ||
| Q4 24 | $-4.7M | $42.0M | ||
| Q3 24 | $162.0K | $-14.5M | ||
| Q2 24 | $6.9M | $-7.3M | ||
| Q1 24 | $6.5M | $-6.7M |
| Q4 25 | $3.3M | — | ||
| Q3 25 | $202.0K | $-47.2M | ||
| Q2 25 | $4.3M | $-39.6M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | $-5.0M | $41.7M | ||
| Q3 24 | $-176.0K | $-14.6M | ||
| Q2 24 | $6.4M | $-7.3M | ||
| Q1 24 | $6.0M | $-6.8M |
| Q4 25 | 8.5% | — | ||
| Q3 25 | 0.6% | -145.4% | ||
| Q2 25 | 11.5% | -252.2% | ||
| Q1 25 | — | -512.1% | ||
| Q4 24 | -12.4% | 48.2% | ||
| Q3 24 | -0.4% | -706.3% | ||
| Q2 24 | 19.5% | -1463.4% | ||
| Q1 24 | 15.3% | — |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | 0.6% | 0.3% | ||
| Q3 24 | 0.8% | 6.8% | ||
| Q2 24 | 1.5% | 7.6% | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 9.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -19.76× | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.85× | — | ||
| Q1 24 | 2.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
